Skip to content
Recall Observatory FDA recall evidence

Drug product

Glipizide XL (glipizide) extended-release tablets 5 mg 500-tablet bottle, Rx only Distributed by: Greenstone LLC. Peapack, NJ 07977 --- NDC 59762-0541-2

D-0010-2019

September 20, 2018

Class II

Product summary

Firm
Pfizer Inc.
Event
Event 81028
Status
Terminated
Classification
Class II
Quantity
7777 bottles
Official record key
drug-enforcement:D-0010-2019

Official wording

Reason: CGMP Deviations; rejected product was used to manufacture final bulk lot

Code information: Lot: T71137 Exp. Feb. 2022

Distribution pattern: Nationwide

Derived failure modes

  • Manufacturing or process control

    reason.manufacturing_process_control · v1.0.0

    CGMP Deviations